SciBase Holding AB (5J30)

Overview

SciBase Holding AB (publ) is a pioneering medical technology company that specializes in crafting and distributing innovative instruments tailored for the diagnosis of skin cancer and various skin conditions, providing its services not only across Europe but also on an international scale. The company is segmented into two main operational divisions: Skin Cancer and Skin Barrier Assessment, showcasing its comprehensive approach towards skin health. Established in 1998, SciBase has positioned its headquarters in Sundbyberg, Sweden, marking its presence as a significant player in the medical technology landscape with a strong focus on improving dermatological diagnostic methods.

Products and Services

SciBase Holding AB (publ) offers an array of products designed to meet the diverse needs within the dermatology field:

• Nevisense: This advanced point of care platform revolutionizes the process of skin cancer detection by offering a reliable, non-invasive method primarily aimed at identifying melanoma. Its cutting-edge technology allows clinicians to assess the risk of this harmful skin condition accurately, facilitating early intervention and potentially saving lives.
• Nevisense Go: Building on the foundations laid by Nevisense, the Nevisense Go variant further simplifies the procedure for detecting not just melanoma but also non-melanoma skin cancers. Its portable design and ease of use make it an invaluable tool for healthcare providers, enabling efficient, on-the-spot skin assessments regardless of the clinical setting.
• Skin Barrier Assessment: Beyond cancer detection, SciBase’s product range extends to evaluating the skin’s barrier functionality. This segment underscores the company's commitment to addressing a broad spectrum of skin conditions, offering crucial insights into the skin's health and guiding appropriate treatment strategies.